Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.
Fatigue is a common symptom in patients with advanced kidney disease, with implications for quality of life (QoL) and clinical outcomes. Fatigue is a complex, multidimensional, and multifactorial phenomenon, which has been defined as 'extreme and persistent tiredness, weakness or exhaustionmental, physical or both'. 1, 2 Common symptoms also include reduced motivation and physical activity, in addition to general lethargy. Renal patients adjust the timing and intensity of their daily activities in order to accommodate their fatigue. 3, 4 For example, some dialysis patients who suffer from post-treatment fatigue require more than 3 h of rest after each session to recover, 5 which is a considerable burden on top of the treatment regimen. Accordingly, the management of fatigue is an important clinical priority for enhancing the patients' QoL. 6 In addition to recognizing fatigue and its severity, it is important to consider the sociodemographic, physiological, and psychological correlates of fatigue in chronic kidney disease (CKD), end-stage renal disease, and transplantation 7 in order to develop and test treatment models specific to these settings. 8 The purpose of this review is to discuss the assessment methods, prevalence, correlates, and the main outcomes associated with fatigue in patients with kidney disease. This review also examines possible interventions to improve fatigue and concludes by defining some future research directions.
ASSESSMENT OF FATIGUE IN CKD
Fatigue assessment tools are generally self-report measures, which are either evaluative, assessing the severity of fatigue, or discriminative, which have the purpose of differentiating fatigued from nonfatigued individuals. 9 Discriminative tools use cutoffs, which are used to indicate fatigue 'caseness'. Several fatigue measures have been shown to hold good psychometric properties in patients with chronic illness. 10 When choosing a fatigue instrument it is important to consider the particular aspect of fatigue intended for study (i.e. unidimensional/multidimensional measure), the psychometric properties of the measure, and the population in which the scale has been used previously. 10 Many of the widely used scales are not specific for kidney patients but have been applied to a variety of other conditions. Although most fatigue instruments measure the overall experience of fatigue during a period of weeks or months, dialysis patients also experience day-to-day and diurnal variation in fatigue.
Ecological momentary assessment procedures have been used to measure fatigue in patients receiving intensive cancer therapy 11 and could be used in the dialysis population to improve our understanding of fatigue and its variation over time, particularly over the interdialytic period. Listed below are some of the most frequently used scales for measuring fatigue in renal patients. For a more detailed review on the assessment of fatigue in chronic illness, see Dittner et al. 12 
SF-36 vitality subscale
The four-item SF-36 vitality subscale is often used as a measure of fatigue. Scores range from 0 to 100, with higher scores reflecting higher energy levels. 13, 14 The concept of vitality is considered to be at the opposite pole to fatigue on a fatigue-vitality continuum. 15 However, the vitality construct captures the reduction in energy level but fails to reflect other aspects of fatigue such as lack of motivation and weakness. 7 
Fatigue severity scale
The fatigue severity scale is a nine-item unidimensional questionnaire 16 scored on a seven-point Likert scale, with high sum scores indicating greater fatigue. The scale's psychometric properties have been corroborated by studies in multiple diseases, including fibromyalgia, 17 multiple sclerosis, 18, 19 chronic hepatitis, 20 and Parkinson's disease. 21, 22 Overall, the fatigue severity scale has been shown to have a good test-retest reliability and a high internal consistency. 12 Visual analog scale to evaluate fatigue severity
The visual analog scale is a unidimensional scale in which a 100-mm line is anchored at either end: by 'no tiredness at all' at the left end and 'complete exhaustion' at the other. The intensity of fatigue is measured in millimeters from the low (left) end of the scale with, again, a higher score indicating an increased level of fatigue. Studies have suggested that the descriptiveness of the visual analog scale to evaluate fatigue severity is considerably lower compared with other measures. 23 Furthermore, the scale might fail to differentiate between sleepiness and fatigue. 24 
Multidimensional fatigue inventory
The multidimensional fatigue inventory 25 contains 20 statements that are organized into five dimensions of fatigue (general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation). A global fatigue score combining results from the five dimensions ranges from 20 to 100, with higher scores indicating higher levels of fatigue. However, the hemodialysis (HD) population has shown difficulty in understanding the instrument. 26 Although the above scales have generally shown adequate psychometric properties, future work needs to evaluate their performance in patients with kidney disease. Currently there are no robust data specific for CKD to recommend a particular measure. For use in routine clinical practice, a simple visual analog scale may provide a useful and quick assessment. Although not widely used in the renal literature, the Chalder fatigue scale 27 measures both mental and physical fatigue, thus evaluation of this measure in CKD would be of interest.
PREVALENCE OF FATIGUE IN RENAL PATIENTS
Fatigue is one of the most frequently reported symptoms in renal disease patients. [28] [29] [30] Compared with the general population, 31,32 dialysis patients report far higher fatigue levels. [33] [34] [35] [36] [37] [38] A significant proportion of patients with renal disease report problematic levels of fatigue (Figure 1) , 28, 29, [37] [38] [39] [40] [41] [42] [43] [44] [45] at rates comparable to other physical conditions. 46 However, the exact prevalence remains contentious as most of the research has focused on the HD population, neglecting transplant and peritoneal dialysis (PD) patients. The estimated prevalence of fatigue ranges between 42 and 89% according to treatment modality and the instruments used to measure the presence of fatigue. A recent investigation using visual analog scale reported that 81.5% of HD patients experienced fatigue. 29 A similarly high prevalence of fatigue in the HD population (77.9%) is reported elsewhere, 43 although lower rates are seen when using the SF-36 vitality subscale (41.9%, Figure 1 ). 39 
CORRELATES OF FATIGUE IN CKD Sociodemographic factors
CKD fatigue has a complex multifactorial etiology (Figure 2 ). Studies indicate that women report significantly higher levels of fatigue than men, 29, 35, 37, 38, [47] [48] [49] although others report no gender association. 34, 39, 47, 50 Gender differences could reflect greater symptom reporting in females compared with males. [51] [52] [53] [54] Age is also fairly consistently associated with higher fatigue levels in renal patients 35, [37] [38] [39] 42, 48, [55] [56] [57] [58] [59] with those over 60 years of age reporting higher levels of fatigue. 55 The age-fatigue relationship might be explained by differences in dialysis vintage, physical activity, malnutrition and inflammation, and greater age-related multi-morbidity 60 resulting in higher reports of fatigue in the elderly. It has also been suggested that with age there may be a shift in patients' report of fatigue, owing to some level of accommodation for or acceptance of reduced activity levels. 61 There is some indication that fatigue is less prevalent in black and Asian patients, 42, 62, 63 although data are conflicting 34 and warrant further enquiry. Social and situational factors including education, and marital and employment status have also been explored in relation to fatigue. Karadag et al. 47 found that education was associated with fatigue severity: those who were graduates had higher fatigue scores than other groups. Four recent studies have linked unemployment to fatigue, 37, 42, 48, 58 which could be related to lower mood-and greater illness-related disability. Finally, marital status can have an impact on fatigue, with single patients generally reporting feeling more energetic compared with married patients, 35, 55, 59 although marriage could also be a reflection of older age, a confounding factor. Nonetheless, this association has not been supported by other researchers, 47, 50 hence the underlying mechanisms of the link between fatigue and these sociodemographic factors should be explored further.
Clinical factors
Multiple studies have shown that extra renal multi-morbidity is significantly higher for fatigued than for nonfatigued HD patients. 39, 42, 64 Multi-morbidity leads to greater burden and stress, more time spent in hospital accompanied by the need for additional therapies, all factors which may contribute to heightened fatigue. 39 Furthermore, a relationship exists between fatigue and poor physical functioning, 48, 50 although causality remains an issue. In patients with endstage renal disease, side effects related to renal replacement therapy and worsening morbidity combine to discourage physical activity (for a detailed review on physical exercise in patients with CKD, see Kosmadakis et al. 60 ). Studies have consistently reported that there is a bidirectional relationship between physical inactivity and fatigue in patients undergoing dialysis. 35, 41, 51 Nutrition and sleep have also been explored by a number of studies. A recent study showed that anorexia and fatigue are strongly related, with the frequency of fatigue being significantly higher in anorexic than in nonanorexic patients. The presence of both anorexia and fatigue in HD patients was also associated with significantly higher levels of interleukin-6 (IL-6) and C-reactive protein (CRP). 64 Joshwa et al. 36 reported an association between daytime sleepiness, poor night-time sleep, and fatigue; results that were supported in both HD 50, 65 and PD patients. 66, 67 In addition, Sanner et al. 15 found that the severity of sleep-related breathing disorders was associated with levels of vitality.
Treatment modality and fatigue
Dialysis is associated with a number of side effects, including fatigue. 68 Approximately 86% of patients experience postdialysis fatigue ranging from mild-to-severe. 69 Feelings of fatigue peek at the end of a dialysis session and are at their lowest during the interdialytic period. 70 Fatigue is moderately associated with dialysis recovery time, 70 with approximately a quarter of patients returning back to their baseline within a few minutes of ending dialysis, around a third recovering by the time they reached home, and almost a quarter only recovering by the following morning. 29 Longer dialysis recovery time is associated with mortality, 71 possibly as a result of higher inflammation. 72 Post-dialysis fatigue is influenced by several factors including osmotic disequilibrium, blood membrane interactions, ultrafiltration, diffusion, and greater tumor necrosis factor. 5, 73, 74 Recovery time from dialysis and post-dialysis fatigue has been shown to improve significantly with more frequent dialysis regimens. 75, 76 Type and duration of renal replacement therapy have also been investigated in relation to fatigue. Transplant recipients report lower levels of fatigue compared with HD, PD, and CKD patients. 34 A more recent study revealed that PD patients were the most fatigued and least active, whereas transplant recipients engaged in most activities, even when fatigue was high. 35 The data on duration of dialysis are mixed and contradictory. Karadag et al. 47 reported higher fatigue scores for patients who had started dialysis more recently, supporting findings from the HEMO study. 42 It may be that over time patients also begin to accept and adapt to the treatment regimen, which may positively impact fatigue. 77 In contrast, Letchmi et al. 78 found a significant relationship between fatigue and dialysis vintage, with patients who had undergone treatment for more than 2 years experiencing high levels of fatigue. An explanation for the latter findings may be that, although with time patients become accustomed to the dialysis routine, their coping mechanisms in response to symptoms may remain unchanged. 78 However, others 34, 44, 50, 51 report no relationship between the duration of renal replacement therapy and fatigue levels experienced by patients. Regarding dialysis adequacy (Kt/V), PD Kt/V has been associated with fatigue, 79 although others report no association between HD Kt/V or dialysis vintage and fatigue levels. 37 The mixed findings regarding Kt/V are likely the result of homogeneity observed within the respective studies. 40 The state of current knowledge concerning the differences between generalized fatigue and dialysis treatment-related fatigue is still unclear, therefore further research is needed to discern the mechanisms involved in these two processes. 68, 70 Biochemistry and hematology factors Biochemistry and hematology factors have also been investigated with regard to fatigue in renal patients and include factors such as anemia, inflammatory cytokines, hemoglobin (Hb), and serum albumin. The majority of patients with CKD are anemic 80 owing to multiple factors, including the inability to produce erythropoietin. The relationship between anemia and fatigue has been studied extensively and there is little question that severe anemia can cause fatigue. Indeed, anemia affects normal physiological functioning and also leads people to experience increased tiredness and reduced ability to undertake daily activities. In a retrospective study, 38 Hb levels were consistently significantly lower in PD patients with fatigue-results that have been supported across the spectrum of advanced kidney disease. 58, [81] [82] [83] [84] However, a number of studies report no correlation between Hb levels and fatigue. 34, 37, 44, 50, 51, 59, 78, 79 The connection between the two has been further explored by studies that have administered erythropoietin-stimulating agents (ESA) to improve anemia. Bonner et al. 33 found a significant improvement in fatigue levels after 12 months of ESA. Finally, a recent systematic review of the impact of ESA in dialysis patients 85 found that a partial correction of anemia with ESA showed the largest improvements in fatigue for patients with baseline Hb levels o10 g/dl.
Chronic inflammation has recently been suggested to have a significant role in the onset of fatigue in renal patients. Inflammatory cytokines may result in fatigue directly through the central nervous system, pituitary gland, hypothalamus, and adrenal glands or indirectly through sleep and psychological disorders. For a detailed review of the role of cytokines in HD see Pertosa et al. 86 Significantly higher IL-6 and CRP levels have been observed in fatigued dialysis patients compared with nonfatigued patients. 34, 61 A recent study reports a significant, albeit small, positive correlation between fatigue (Chalder fatigue scale) and IL-6, although no association was observed between CRP and fatigue. 87 Jhamb et al. 62 report that poor vitality was significantly related to both IL-6 and CRP. Other studies 39, 82, 88, 89 have found that serum albumin and creatinine levels were significantly lower in patients with fatigue and depression, respectively. In addition, serum creatinine is predictive of decreasing vitality over time. 62 However, most have failed to demonstrate associations between fatigue and creatinine 7,37 and fatigue and serum albumin levels. 37, 49, 50, 79 Calcium and phosphate levels have been associated with fatigue in renal patients, 58, 79 although data are conflicting. 7, 37, 39, 44, 49, 50 In summary, the variability in reported fatigue levels is only partially explained by biochemistry and hematological factors. It should also be noted that some studies fail to suitably control for comorbidity and other potentially confounding factors that may have an impact upon fatigue levels. This highlights the importance of understanding other factors, particularly psychological, that may help to further explain fatigue levels in advanced kidney disease.
Psychosocial factors
There are a number of psychosocial factors that have been related to fatigue in renal patients, including depression, health-related QoL, anxiety, loneliness, social support, and suicide risk. Although the direction of these associations cannot be inferred, it appears that the relationship between fatigue with physiological and psychological factors, is reciprocal. 50 Of the psychological factors, depression has been the most extensively studied. Fatigue and depression are interrelated, and depression may manifest as feelings of lack of energy and tiredness. 7 Multiple studies on dialysis patients 5 41 showed that patients who reported being fatigued upon arising had significantly higher average depression scores than their counterparts who felt mediocre or better upon arising. In addition, Chen et al. 90 found that not only depression but also suicide risk correlated with fatigue in HD patients. Studies also show a significant association between fatigue and anxiety in HD patients. 39, 50, 90 However, others 78 have found no significant relationship between fatigue and depression and between fatigue and anxiety. Differential findings could be justified by the measurement scale used in the study, that is, the Depression Anxiety Stress Scale as opposed to the Beck Depression Inventory that was used in the majority of the studies above. Indeed, the Depression Anxiety Stress Scale and the Beck Depression Inventory have been found to be only moderately correlated, and the Depression Anxiety Stress Scale does not include several items, which are not uniquely related to depression, including weight loss, loss of libido, irritability, loss of appetite, and somatic preoccupation. 92 Moreover, the studies above were all conducted on dialysis patients and did not include transplant patients. As successful transplantation has been associated with reduced levels of anxiety and depression compared with those experienced by dialysis patients, 93 further studies regarding the relationship between depression, anxiety, and fatigue in transplant patients should therefore be considered, particularly in relation to graft function and rejection episodes.
Akin et al. 55 described a relationship between fatigue, loneliness, and self-care: as levels of loneliness and fatigue increased, the self-care ability of HD patients decreased, which could help explain poor clinical outcomes associated with fatigue. Bolstering social support may therefore be an important factor to improve fatigue symptoms and self-care behavior in dialysis patients. 94 Indeed, Karadag et al. 47 found that patients with severe fatigue perceived lower social support from family and friends. Although similar results have been reported in other disease groups, some renal studies have failed to find a relationship between fatigue and social support. 43, 83 
ASSOCIATED OUTCOMES
Fatigue symptoms are associated with all cause and cardiacrelated mortality in HD patients. 42, 62 Koyama et al. 57 showed that highly fatigued HD patients exhibited a significantly greater risk for cardiovascular events, but not mortality. The relationship was independent of the well-known risk factors, including age, diabetes, cardiovascular disease history, inflammation, and malnutrition markers.
There are a number of ways through which fatigue may be associated with poor outcomes. Chaudhary 95 suggested that fatigue is one of the causes of treatment dropout in PD patients. As withdrawal from dialysis has been found to be the most common cause of death after CVD, 96 fatigue may affect mortality through dialysis non-adherence. Poor nutrition could also have a role in mortality as it is well established that serum albumin predicts survival in dialysis patients. 97 Fatigue is also associated with and is a feature of depression, which is well recognized to predict mortality in end-stage renal disease patients. 98, 99 Whether fatigue is an independent predictor of outcome, above and beyond the effects of depression, still requires further evaluation.
Multiple studies have found that fatigue is significantly associated with lower QoL in renal patients. 42, 62, 100 A longitudinal study found that fatigue was strongly negatively correlated with physical and mental health over time, with higher fatigue levels leading to lower health-related QoL 12 months later. 33 As health-related QoL is strongly associated with higher risk of mortality and hospitalization in dialysis patients, 101 more research is required to assess whether interventions to improve fatigue and QoL could improve clinical outcomes.
NONPHARMACOLOGICAL TREATMENT OF FATIGUE IN RENAL PATIENTS
As the etiology of fatigue in renal patients is still largely unknown, no consistent treatment model exists. Studies that have examined therapeutic strategies are few, heterogeneous, and generally have methodological limitations. Treatment of fatigue can be divided into pharmacological and nonpharmacological interventions. Pharmacological interventions include: l-carnitine, growth hormone, nandrolone decanoate, and vitamin c supplementation (for a review see Bossola et al. 40 ). For the purpose of this review we will focus on nonpharmacological interventions for the treatment of fatigue.
Much evidence supports the positive effects of regular physical activity on fatigue. 102 In dialysis patients, both aerobic and resistance exercises are associated with improvements in muscle structure and function, cardiac function, blood pressure, psychological adaptation, and QoL. 60, 103, 104 A recent randomized controlled trial 105 revealed how performing a leg ergometry exercise within the first hour of HD session can significantly improve fatigue and activity levels at 8 weeks after intervention. In addition, van Vilsteren et al. 106 reported improved vitality levels following a low-medium intensity exercise program. Partial data from a study in pediatric patients showed decrease in perceived fatigue after an exercise program, although adherence to the program was low. 107 Indeed, when exercise therapy is available in routine practice, uptake by dialysis patients is low. A likely contributor to poor uptake and adherence may be the fact that exercise protocols have been developed primarily for research purposes and hence may be unsuitable for patients with poorer health and multi-morbidities due to the frequency and vigor of particular regimens. 60 Furthermore, patients' illness and treatment perceptions have been shown to predict adherence in dialysis patients, 108,109 thus may also help explain uptake and adherence to exercise interventions. Moreover, evidence of plausible mechanisms regarding the benefits of physical activity upon fatigue levels remains unclear. 102 It is well established that exercise interventions improve physical QoL in both clinical and healthy populations 110 and can lead to reductions in proinflammatory cytokines, 111 which could have an impact upon fatigue levels. In HD patients, physical inactivity is associated with greater post-dialysis fatigue. 69 Although data are inconclusive, 112 small studies in dialysis patients have indicated reductions in CRP following both stationary dialysis cycling 113, 114 and high-intensity, progressive resistance training. 115 Other studies have shown that exercise regimens are associated with improvements in nutritional parameters and QoL in CKD, 104, 116 mood, 117 and sleep quality. 114 However, given that many of these studies suffer from small sample sizes, or other methodological concerns, further longitudinal studies are required to understand the mechanism through which exercise may lead to improved fatigue levels in dialysis patients.
Cognitive-behavioral therapy (CBT) for sleep disturbances in dialysis patients has shown promising effects on fatigue, with modest but significant reductions in fatigue scores after intervention. 118, 119 A very small individual sleep intervention study by Yngman-Uhlin et al. 66 also revealed similar results, with four out of nine patients reporting reductions in fatigue. Although these findings corroborate the association between sleep problems and fatigue, larger investigations are needed to support these data. A small number of studies have been conducted on alternative therapies for fatigue in renal patients. These encompass: acupressure, reflexology, and yoga. Tsay 65 conducted an randomized controlled trial on the effect of acupressure and found that patients in the acupressure group, not only had significantly lower levels of fatigue but also had significantly better sleep quality compared with patients in the control group. A recent study by Ozdemir et al. 89 evaluated the effect of foot reflexology on fatigue on HD patients and reported significant differences in fatigue levels between the experimental and the control group. Finally, an randomized controlled trial in HD patients found significant effects of yoga on fatigue, with a 55% reduction of fatigue following treatment compared with the control group. 120 Although these results look promising, the studies used small samples and no follow-up data were included, hence the generalizability and long-term outcomes of these interventions on fatigue are yet to be defined. Indeed, a recent meta-analysis on the effects of yoga interventions in different chronic illnesses was not able to demonstrate effects of yoga on fatigue levels. 121 As fatigue is a multifactorial problem, a multidisciplinary approach to treatment may be the most appropriate approach to treatment, with the need to consider treatment models adopted in other long-term medical conditions ( Figure 3 ). For example, tackling unhelpful cognitions and behaviors thought to perpetuate fatigue would be an important target of fatigue intervention in dialysis patients (i.e., increasing perceptions of control over symptoms, increase understanding, seeing fatigue as time-limited and as having less serious consequences). Owing to the large prevalence of fatigue among renal patients, it is important for all renal providers to receive training on the identification and treatment of fatigue. Anemia and inflammation appear to be the primary physiological correlates of fatigue in renal patients, albeit with small-moderate effect sizes, and remain targets for treatment of fatigue in advanced kidney disease. However, acknowledging the growing evidence that supports the links between fatigue and psychosocial factors, clinicians should address these aspects in order to comprehensively address fatigue. Moreover, given the bidirectional relationship between fatigue and physical inactivity, it could be useful to incorporate physical rehabilitation as part of the kidney patients' care. 60 Similarly, following guidelines from the UK National Institute for Health and Clinical Excellence, 122 patients with CKD should be encouraged to exercise by providing them with information on the benefits of exercise on fatigue. Sleep and nutrition should also be factors to consider when developing nonpharmacological interventions. Finally, the different fatigue levels in relation to dialysis duration and frequency and rates of ultrafiltration suggest that clinicians may wish to regard these as potentially modifiable factors to improve fatigue in dialysis patients.
CONCLUSIONS AND FUTURE DIRECTIONS
Fatigue is a common phenomenon among patients with kidney disease, yet it is often unrecognized and undertreated. The lack of a comprehensive definition and a relatively poor understanding of its pathogenesis and measurement issues combine to make treatment development challenging across the spectrum of advanced kidney disease. Studies that address fatigue have found that fatigue is more prevalent among older, white women. Behavioral factors such as: physical inactivity, sleep, and nutrition appear to have a significant impact on fatigue. The type of renal replacement therapy may also have an effect on fatigue, with transplant patients displaying significantly less fatigue than patients on dialysis. However, there is conflicting evidence on how the duration of dialysis affects fatigue in renal patients. There is a need to conduct large-scale longitudinal studies in order to determine how these factors are associated with fatigue over time. Interesting findings have been made from the investigation of fatigue and biochemistry and hematology factors, with studies reporting significant correlations between fatigue and hemoglobin levels, inflammatory and nutrition markers, and dialysis adequacy markers. However, results are not always consistent and further insights into how behavioral and disease-related factors interact with each other to cause fatigue would deepen our understanding of the pathology and treatment of fatigue. Research regarding the relationship between fatigue and psychosocial factors is not extensive and most findings are focused on depression and anxiety. Nevertheless, the different etiologies and clinical outcomes of depression and fatigue indicate two correlated but distinct phenomena, which require specific interventions. It has been shown in cancer patients that depression and fatigue share no structural relationship over time. 123 Further studies are therefore needed to address other potential correlates, including cognitive and behavioral factors, where research is limited in this patient population. Indeed, research from the multiple sclerosis literature 124 shows that changes in beliefs about fatigue have a crucial role in CBT for multiple sclerosis fatigue. Having more positive views about fatigue (i.e., having more control over it, having a better understanding of it, seeing it as time-limited and as having 130, 131 and CBT in patients with cancer. 132 These treatment protocols have been based on multifactorial models of understanding fatigue in these populations, which include an interaction between biological, psychological, and social factors. [133] [134] [135] [136] Drawing from theories and research in other clinical populations can provide us with a better appreciation of the way different factors contribute to fatigue in general, and illuminate appropriate areas for future research and interventions in patients with advanced kidney disease.
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